These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15714664)

  • 1. Fluoroquinolone-resistant Salmonella Paratyphi A.
    Adachi T; Sagara H; Hirose K; Watanabe H
    Emerg Infect Dis; 2005 Jan; 11(1):172-4. PubMed ID: 15714664
    [No Abstract]   [Full Text] [Related]  

  • 2. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-resistant Salmonella enterica serotype paratyphi A in India.
    Chandel DS; Chaudhry R; Dhawan B; Pandey A; Dey AB
    Emerg Infect Dis; 2000; 6(4):420-1. PubMed ID: 10905982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A need to revise ciprofloxacin breakpoints for Salmonella in human beings.
    Gupta V; Kaur J
    Int J Infect Dis; 2008 Nov; 12(6):e143-4. PubMed ID: 18514007
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp. enterica serotype Paratyphi A.
    Harish BN; Madhulika U; Parija SC
    J Med Microbiol; 2004 Aug; 53(Pt 8):819. PubMed ID: 15272072
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.
    Joshi S; Amarnath SK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):308-10. PubMed ID: 16950486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone resistance among Salmonella enterica serovar Paratyphi A in Pondicherry.
    Harish BN; Menezes GA; Sarangapani K; Parija SC
    Indian J Med Res; 2006 Nov; 124(5):585-7. PubMed ID: 17213529
    [No Abstract]   [Full Text] [Related]  

  • 9. Identifying the mechanism underlying treatment failure for Salmonella Paratyphi A infection using next-generation sequencing - a case report.
    Park HR; Kim DM; Yun NR; Kim CM
    BMC Infect Dis; 2019 Feb; 19(1):191. PubMed ID: 30808284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin resistance in Salmonella paratyphi A.
    Brown NM; Millar MR; Frost JA; Rowe B
    J Antimicrob Chemother; 1994 Jun; 33(6):1258-9. PubMed ID: 7928825
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial resistance trends in blood culture positive Salmonella Paratyphi A isolates from Pondicherry, India.
    Menezes GA; Harish BN; Khan MA; Goessens W; Hays JP
    Indian J Med Microbiol; 2016; 34(2):222-7. PubMed ID: 27080779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatives to ciprofloxacin use for enteric Fever, United kingdom.
    Threlfall EJ; de Pinna E; Day M; Lawrence J; Jones J
    Emerg Infect Dis; 2008 May; 14(5):860-1. PubMed ID: 18439388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin breakpoints in enteric fever--time to revise our susceptibility criteria.
    Rodrigues C; Kumar NJ; Lalwani J; Mehta A
    Indian J Med Microbiol; 2008; 26(1):91. PubMed ID: 18227614
    [No Abstract]   [Full Text] [Related]  

  • 16. Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin.
    Dimitrov T; Udo EE; Albaksami O; Kilani AA; Shehab EMR
    J Med Microbiol; 2007 Feb; 56(Pt 2):277-279. PubMed ID: 17244813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone resistance trends and animal drug use: a retrospective analysis.
    Radostits OM
    Int J Infect Dis; 2004 May; 8(3):187-9; author reply 190-2. PubMed ID: 15109595
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.
    Zaytoun OM; Vargo EH; Rajan R; Berglund R; Gordon S; Jones JS
    Urology; 2011 May; 77(5):1035-41. PubMed ID: 21420152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep-seated resistance in relapsed paratyphoid fever.
    Cooke GS; Cooke FJ; Stone M; Turner K; Al-Nahhas A; Win Z; Wain J; Rogers TR; Friedland JS; Bamford KB
    Clin Infect Dis; 2006 Jun; 42(11):e92-4. PubMed ID: 16652303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital.
    Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A
    J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.